0 items USD 0.00Search
Your search for "mrrpb5 global her 2 targeted drugs breast cancer market size status forecast 2019 2025" gave back 83406 results.
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. The...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Market Analysis and Insights: Global HER-2 Targeted Drugs for Breast Cancer Market The global HER-2 Targeted Drugs for Breast Cancer market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global HER-2 Targeted Drugs for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The “HER-2 Targeted Drugs for Breast Cancer Industry Forecast” looks at past sales and reviews total world HER-2 Targeted Drugs for Breast Cancer...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global HER2 Target Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
November 2023
Price: USD 3,480.00
According to our Publisher latest study, the global Drugs for HR+/HER2- Advanced Breast Cancer market size was valued at USD million in 2022 and is...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Drugs for HR+/HER2- Advanced Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Highlights The global Targeted Drugs for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global HER2 Target Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the HER2 Target Drugs is...
Catalog:
LPI
November 2023
Price: USD 3,660.00
The global HER2 Target Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global Drugs for HR+/HER2- Advanced Breast Cancer market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during...
Catalog:
GIR
February 2023
Price: USD 4,480.00
Market Analysis and Insights: Global Targeted Drugs for Breast Cancer Market The global Targeted Drugs for Breast Cancer market is projected to grow...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
